Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joanne Quan, MD
Bayhill Therapeutics Inc.
Study Director - Len Harrison, MD
Walter and Eliza Hall Institute of Medical Research
Study Chair - Peter Gottlieb, MD
University of Colorado, Denver
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peninsula Clinical Research Centre
Kippa-Ring, Queensland, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- Eastern Clinical Research Unit
Ringwood East, Victoria, Australia
- Fremantle Hospital
Fremantle, Western Australia, Australia
- Middlemore Hospital
Otahuhu, Auckland, New Zealand
- Christchurch Hospital
Christchurch, Canterbury, New Zealand
- Waikato Regional Diabetes Service
Hamilton, Waikato Region, New Zealand
- the Diabetes Centre
Newtown, Wellington Region, New Zealand
- University of Alabama at Birmingham School of Medicine
Birmingham, Alabama, United States
- Valley Research
Fresno, California, United States
- Barbara Davis Center for Childhood Diabetes
Aurora, Colorado, United States
- Private Practice
Denver, Colorado, United States
- Medstar Research Institute
Washington D.C., District of Columbia, United States
- University of Miami, Miller School of Medicine, Diabetes Research Institute
Miami, Florida, United States
- Private Practice
Wellington, Florida, United States
- Creighton Diabetes Center
Omaha, Nebraska, United States
- Diabetes and Glandular Disease Center
San Antonio, Texas, United States
- Benaroya Research Institute at Virginia Mason
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2006
- Primary completion
- 31 May 2011
- Completion
- 31 May 2011
- Last update posted
- 28 Jun 2011
- Registered enrollment
- 80
- Registry id
- NCT00453375
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.